Why Summits

World Drug Safety Summit

5–6 Jun 2025 | Basel, Switzerland

Petros Mavrogenis

Global Head of Vigilance Process Excellence

Novartis

Basel, Switzerland

12 profile visitsSpeakerSpeaker

Petros has been at the forefront of driving Patient Safety & Pharmacovigilance Transformation, Business Process Re-Engineering, and Pharmacovigilance Policy.

My organisation

Novartis

Novartis

Manufacturer

Basel, Switzerland

At Novartis, we are dedicated to reimagining medicine to improve and extend people's lives. As a global healthcare company, we focus on innovative pharmaceuticals and groundbreaking therapies that address significant health challenges. Our commitment to research and development drives us to collaborate with healthcare professionals, scientists, and patients to create solutions that make a meaningful impact. Together, we strive to build a healthier future for communities around the world.
Read more

About me

Background:

Petros Mavrogenis is a distinguished Doctor of Pharmacy from Charles University Prague, with an impressive 25 years of experience in the pharmaceutical industry. Known for being dynamic, passionate, and creative, Petros exemplifies high integrity and exceptional leadership skills. Over the past two decades, Petros has inspired and led teams and organizations by setting an example and continuously developing and mentoring team members.

In recent years, as part of the PV Leadership, Petros has been at the forefront of driving Patient Safety & Pharmacovigilance Transformation, Business Process Re-Engineering, and Pharmacovigilance Policy. Additionally, Petros recently obtained a BA in Medical Ethics and Bioethics, further enhancing his expertise in the field.

Background:

  • Pharmaceutical retail and pharmaceutical software development

  • Sales and Branding in the multinational pharma industry (MSD)

  • Academia: Pharmacology lecturer and Ethics at Nicosia University – School of Science

  • Former Member of the Cyprus Drug Council

  • 16 years at Novartis in various positions:

    • Medical Director/Compliance Officer

    • Medical Governance – Oncology

    • Pharmacovigilance Regional and Global operations

    • Chief Medical Office Quality Assurance Head

    • Director of Medical and Science Policy

    • Head of Vigilance Process Excellence (Operational Excellence)

    • Global Head of Vigilance Process Excellence

Petros brings a wealth of knowledge and experience to the congress, ready to share insights and lead discussions on the future of pharmacovigilance and process excellence.

Social media

Speaker sessions (1)

Thursday, 5 June 2025

11:50 - 12:20